– an update
Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies
Endothelin-1 and the kidney – beyond BP
Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
P/Q-type calcium channel modulators
Can small non-peptide motilin agonists force a breakthrough as gastroprokinetic drugs?
Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists
Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition
Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance
Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation
Effects of pyrazole partial agonists on HCA2-mediated flushing and VLDL-triglyceride levels in mice
The oligopeptide DT-2 is a specific PKG I inhibitor only in vitro , not in living cells
Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist
KCa3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS
Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo
The orphan receptor GPR3 modulates the early phases of cocaine reinforcement
Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability
Involvement of the endogenous hydrogen sulfide/Cav3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice